Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
Sponsor: Charles H. Hood Foundation
This observational or N/A phase trial investigates Leukemia and Myelodysplastic Syndromes and is currently actively recruiting participants. Charles H. Hood Foundation leads this study, which shows 14 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Jul 2025 — Present [monthly]
Recruiting
-
Dec 2024 — Jul 2025 [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Dec 2023 — Jun 2024 [monthly]
Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Recruiting
-
Jun 2023 — Sep 2023 [monthly]
Recruiting
-
Jan 2023 — Jun 2023 [monthly]
Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Recruiting
-
Jun 2022 — Dec 2022 [monthly]
Recruiting
-
Jan 2022 — Jun 2022 [monthly]
Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Charles H. Hood Foundation
- Dana-Farber Cancer Institute
- Rally Foundation for Childhood Cancer Research
For direct contact, visit the study record on ClinicalTrials.gov .